SCHEMBL3452265

SCHEMBL3452265

COC(=O)C1CCCCN1c1cccc(Br)c1

nearest known ligand 0.47

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.43
SLC6A4 P31645 1/20 0.41
SLC6A3 Q01959 1/20 0.41
FKBP1A P62942 1/20 0.40
GAA P10253 1/20 0.40
HPGD P15428 1/20 0.40
BACE1 P56817 2/20 0.39
TP53 P04637 1/20 0.39
L3MBTL4 Q8NA19 1/20 0.39
L3MBTL3 Q96JM7 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
OPRM1 P35372 1/20 0.39
OPRD1 P41143 1/20 0.39
OPRK1 P41145 1/20 0.39
OGFRL1 Q5TC84 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13310423 0.96 ALDH1A1 (0.47) ALDH1A1SLC6A4SLC6A3GAABACE1
SCHEMBL13310419 0.96 ALDH1A1 (0.47) ALDH1A1SLC6A4SLC6A3GAABACE1
SCHEMBL32670201 0.84 FKBP1A (0.42) ALDH1A1FKBP1AGAABACE1
SCHEMBL27378399 0.84 FKBP1A (0.42) ALDH1A1FKBP1AGAABACE1
SCHEMBL29349018 0.84 ALDH1A1 (0.44) ALDH1A1SLC6A4SLC6A3FKBP1AOPRM1
SCHEMBL3448024 0.84 HPGD (0.43) ALDH1A1HPGDTP53L3MBTL4L3MBTL3
SCHEMBL29671561 0.84 FKBP1A (0.47) ALDH1A1SLC6A4SLC6A3FKBP1ABACE1
SCHEMBL27551310 0.84 FKBP1A (0.47) ALDH1A1SLC6A4SLC6A3FKBP1ABACE1
SCHEMBL27379476 0.82 FKBP1A (0.43) ALDH1A1FKBP1AGAABACE1
SCHEMBL11983632 0.81 L3MBTL1 (0.43) HPGDBACE1L3MBTL4L3MBTL3L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100137313-A1 HETEROCYCLIC DERIVATIVES AND METHODS OF USE THEREOF ASTRAZENECA AB 2010-06-03 US disclosed
US-20100137313-A1 HETEROCYCLIC DERIVATIVES AND METHODS OF USE THEREOF ASTRAZENECA AB 2010-06-03 US disclosed
US-20100137313-A1 HETEROCYCLIC DERIVATIVES AND METHODS OF USE THEREOF ASTRAZENECA AB 2010-06-03 US disclosed
WO-2010038081-A2 HETEROCYCLIC DERIVATIVES AND METHODS OF USE THEREOF ASTRAZENECA AB (SE) 2010-04-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100137313-A1 HETEROCYCLIC DERIVATIVES AND METHODS OF USE THEREOF SDHA, SDHB, UROD ALDH1A1 530/4885SLC6A4 3680/4885SLC6A3 3809/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.